Immunogenetic aspects of viral or other environmental factors in schizophrenia

Conference paper
Part of the Key Topics in Brain Research book series (KEYTOPICS)


Neuronal regulation appears to be vulnerable to cytokines of the immune system. Environmental microbial factors can stimulate the production of such cytokines. The type of cytokine, elaborated in the course of acute and chronic infections, depends on the individual immunogenetic disposition. Examples of immune reponses will be discussed that can lead to a polarized overproduction of some cytokines in dependance of the immunogenetic disposition.


Immune Response Gene Paranoid Symptom Autoimmune Hypothesis Immunogenetic Factor Schizophrenic Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kety SS, et al. (1971) Mental illness in the biological and adotpive families of adopted schizophrenics. Am J Psychiatry 128: 302–312PubMedGoogle Scholar
  2. 2.
    Gottesmann II (1991) Schizophrenia genesis. WH Freeman and Company, New YorkGoogle Scholar
  3. 3.
    Nurnberger JJ, Gershon ES (1992) Genetics. In: Paykell (ed) Handbook of affective disorders. Churchill Livingstone, Edinburgh, pp 131–148Google Scholar
  4. 4.
    Yolken RH, Torrey EF (1995) Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 8: 131–145PubMedGoogle Scholar
  5. 5.
    Barondes SH (1993) Molecules and mental illness. Scientific American Library, New York, p V (Preface)Google Scholar
  6. 6.
    Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH (1993) Elevated CSF levels of Interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry 150:9:1408–1410PubMedGoogle Scholar
  7. 7.
    Wilke I, Arolt V, Rothermund M, Weitzsch C, Homberg M, Kirchner H (1996) Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 246: 279–284PubMedCrossRefGoogle Scholar
  8. 8.
    Mc Allister CG, et al. (1995) Increases in CSF levels of Interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am J Psychiatry 152: 1291–1297PubMedGoogle Scholar
  9. 9.
    Denicoff KD, et al. (1987) The neuropsychiatric effects of treatment with Interleukin-2 and lymphokine activated killer cells. Ann Intern Med 107: 293–300PubMedGoogle Scholar
  10. 10.
    Peltonen L (1995) All out for chromosome six. Nature 378: 665–666PubMedCrossRefGoogle Scholar
  11. 11.
    Wucherpfennig KW, Strominger J (1995) Molecular mimicry in T-cell mediated autoimmunity: viral peptides activate human T-cell clones specific for myelin basic protein. Cell 80: 707–718CrossRefGoogle Scholar
  12. 12.
    Mignot M, Tafti M, Dement WC, Grumet FC (1995) Narcolepsy and immunity. Adv Neuroimmunol 5: 23–27PubMedCrossRefGoogle Scholar
  13. 13.
    Großkopf A, Müller N, Malo A, Wank R (1998) Potential role for the narcolepsy-and multiple sclerosis-associated HLA allele DQBl*0602 in schizophrenia subtypes. Schizophr Res 30: 187–189PubMedCrossRefGoogle Scholar
  14. 14.
    Segurado OG, Arnaiz-Villena A, Wank R, Schendel DJ (1993) The multi-factorial nature of MHC linked susceptibility to insulin-dependent diabetes. Autoimmunity 15: 85–89PubMedCrossRefGoogle Scholar
  15. 15.
    Laumbacher B, Wank R (1998) Recruiting HLA to fight HIV. Nature Med [Vaccine Suppl] 4:5:5Google Scholar
  16. 16.
    Robinson D, et al. (1998) IGIF does not drive Thl development, but synergizes with IL-12 for IFNy production, and activates IRAK and NF-KB. Immunity 7: 571–581CrossRefGoogle Scholar
  17. 17.
    Locksley RM, Scott P (1991) Helper T-cell subsets in mouse Leishmaniasis: induction, expansion and effector function. Immunol Today 12: 58–61CrossRefGoogle Scholar
  18. 18.
    Hsu DH, et al. (1990) Expression of Interleukine-10 activity by Epstein-Barr virus protein BCRF1. Science 250: 830–832PubMedCrossRefGoogle Scholar
  19. 19.
    Kuo CC, Shor A, Campbell LA, Fukushi H, et al. (1993) Demonstration of Chlamydia pneumoniae in athrosclerotic lesions of coronary arteries. J Infect Dis 167: 841–849 167: 841-849PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1999

Authors and Affiliations

  • R. Wank
    • 1
  1. 1.Institut für ImmunologieUniversität MünchenMünchenFederal Republic of Germany

Personalised recommendations